Insider Trading & Ownership of Jonathan Violin

Location
Chesterbrook, PA
Summary
The estimated net worth of Jonathan Violin is at least $10,113,603 dollars as of 23 Jan 2026. Jonathan Violin is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $10.1M. Jonathan Violin is the Director of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $14.6K.
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jonathan Violin and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Jonathan Violin has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $10,113,603.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Viridian Therapeutics, Inc.\DE ($10,099,005).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jonathan Violin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director $10,099,005 02 Feb 2023
CBIO GLYCOMIMETICS INC Director $14,598 23 Jun 2025
ATXS Astria Therapeutics, Inc. Director $0 23 Jan 2026
DNTH Dianthus Therapeutics, Inc. /DE/ Director 22 May 2025

Insider Transactions Reported by Jonathan Violin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .